Sourcefit Secures Strategic Investment from 9 Basil, NextGen Ventures, and Rocket Equities
Sourcefit, a leading international business processing outsourcing (BPO) provider with operations centers in the Philippines, South Africa, Dominican Republic and Armenia, has successfully closed a significant strategic investment, attracting investments from prominent players 9 Basil, NextGen Ventures, and Rocket Equities. This financial milestone marks a pivotal moment in Sourcefit's growth trajectory.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20231222601715/en/
The strategic investment round demonstrates a decisive vote of confidence in Sourcefit's business model and potential. Rocket Equities, acting as the financial advisor and investor, helped structure the deal for all parties.
Andy Schachtel, CEO of Sourcefit, expressed gratitude for the support, stating, “Sourcefit is entering an exciting phase of our growth and we plan to use the recent funding round to expand our award-winning BPO and staffing services globally. With a dynamic team of over 1,700 employees, we will continue to deliver comprehensive solutions to a diverse set of clients across a range of industries, helping them to lower costs and significantly improve results.”
In addition to these expansion plans, Sourcefit will continue development of its AI-infused team engagement and digitalization platform. This platform forms the technological backbone of Sourcefit's operations, facilitating seamless collaboration and productivity among remote teams and providing a framework for the complete digital transformation of both the company’s operations and those of clients. This equity financing round underscores the company’s ambition to redefine the boundaries of BPO solutions and set new standards in the industry.
Kris Panijpan, Managing Partner of 9 Basil Group, an independent private investment group with a Southeast Asian mandate, added, “We aim to leverage our network, expertise in various sectors, and extensive experience in capital markets to identify exceptional growth opportunities for Sourcefit.”
Jimmy Quach, CEO of NextGen Ventures, noted: “Sourcefit is a customer-centric BPO that delivers exceptional value to clients through cutting edge technology enablement; including its AI and digitalization platform and its awarding-winning best-place-to-work culture for high employee engagement and productivity. We look forward to working with Andy to better serve Sourcefit’s customers by assisting with Sourcefit's expansion goals and advising on the technology roadmap.”
As Sourcefit embarks on this exciting phase of growth, the investment round and strategic partnerships underscores the resilience and potential of the company.
About Sourcefit
Sourcefit is a leading international business processing outsourcing (BPO) provider with operations centers in the Philippines, South Africa, Dominican Republic and Armenia. Focused on providing custom offshore and nearshore staffing solutions, the company currently supports a wide range of processes for over 200 clients in various industries, including IT, Finance, Healthcare, Retail, E-Commerce, Legal, Real Estate, Telecom, and Advertising. The company has a track record of over 14 years and employs over 1,700 dynamic, hard-working professionals.
About 9 Basil Group
9 Basil Group is a Southeast Asia-focused independent private investment group. Recognized as a preferred local partner and value-enhancing investor, we strategically partnered with several well-established families and institutions across the SEA region. Our distinguished reputation is founded on the ability to deliver immediate, concrete value as a trustworthy and discreet partner. The team has diverse backgrounds, leveraging accumulated expertise across various sectors, extensive experience in capital markets, and a profound understanding of the local market network.
About Nextgen Ventures
Nextgen Ventures is a family office based in Singapore with investment in companies across the Asia-Pacific Region. Our entrepreneurial roots and track record allows us to partner with founders and their management team to scale up businesses at the intersection of brands, service, and technology, while creating and delivering outstanding returns to our stakeholders and partners. We leverage our human and financial capital to help companies build sustainable businesses and achieve their full potential.
About Rocket Equities
Rocket Equities is a Southeast Asia-focused financial advisory firm. We work with market leaders to raise capital via debt & equity markets, enable market expansion through M&A, and create a lucrative exit for founders by leveraging our network of 300+ professional investors composed of Venture Capital, Private Equity, Corporates, and Sovereign Wealth Funds in APAC.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20231222601715/en/
Contact information
Media:
Ayele McCarthy
Email: ayele@elkordyglobal.com
Matt Santoro
Email: matt@elkordyglobal.com
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
New Published Data Confirms Nemluvio ® (Nemolizumab) Can Rapidly Relieve Itch and Improve Sleep in as Early as Two Days in Both Atopic Dermatitis and Prurigo Nodularis17.12.2025 07:00:00 CET | Press Release
Galderma (SIX: GALD), the pure-play dermatology category leader, today released new clinical data confirming nemolizumab’s rapid onset of action on itch and sleep, with significant improvements observed as early as 48 hours after treatment in some patients with atopic dermatitis and prurigo nodularis.1 The findings from post-hoc analyses of the phase III ARCADIA and OLYMPIA clinical trial programs were published in the Journal of the European Academy of Dermatology and Venereology. Nemolizumab is the first approved monoclonal antibody that specifically targets IL-31 receptor alpha, inhibiting the signalling of IL-31.2,5,6 IL-31 is a neuroimmune cytokine that drives itch and other symptoms in both atopic dermatitis and prurigo nodularis.3,4 These new findings reinforce the critical role of IL-31 pathway inhibition in achieving rapid itch response. Atopic dermatitis and prurigo nodularis are debilitating skin conditions that significantly affect quality of life, with symptoms such as per
Mori Memorial Foundation’s Global Power City Index 2025 Sees City Rankings Shift Due to Tourism Gains in East Asia and Inflationary Pressures in the West17.12.2025 04:00:00 CET | Press Release
The Mori Memorial Foundation’s Institute for Urban Strategies, a research body established by Mori Building, Tokyo’s leading urban landscape developer, today published its annual Global Power City Index (GPCI) 2025, a report evaluating the urban competitiveness of 48 major cities worldwide. The report also includes the GPCI–Financial Centers index, an assessment of cities as international financial centers, and the new GPCI–Startup Ecosystems index, which assesses the competitiveness of startup environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251216187692/en/ 48 Major Cities Evaluated in Mori Memorial Foundation’s GPCI-2025 Report This year’s report highlights the remarkable rise of East Asian cities and the stagnation of several Western cities, showing how global challenges, such as geopolitical tensions and regional disparities in inflation, are greatly impacting the performance of major cities worldwide. The r
GE HealthCare and Indonesia’s Ministry of Health to expand access to quality care through the provision of 300+ advanced CT scanners17.12.2025 03:00:00 CET | Press Release
GE HealthCare (Nasdaq: GEHC) today announced it will supply more than 300 CT (computed tomography) scanners under Indonesia’s Strengthening Indonesia’s Health Referral Network (SIHREN) program to deliver equitable, high-quality care to more than 280 million Indonesians. As part of a competitively awarded, multi-year contract, GE HealthCare will supply the advanced CT scanners to public hospitals across all 38 provinces, including urban and remote areas. The CT scanner procurement under SIHREN was conducted through a fully competitive international tender process governed by the World Bank’s procurement regulations. SIHREN is the largest healthcare infrastructure investment in Indonesia’s history and among the largest multilateral health projects globally. SIHREN aims to modernize the national referral system and expand access to diagnostics and treatment across the archipelago, with a focus on non-communicable diseases (NCD) management, maternal health, and pandemic resilience. By mode
IDWS 2025 Concludes with Focus on Global Knowledge Exchange, Financial Opportunities, and Scalable Water Solutions16.12.2025 20:03:00 CET | Press Release
The 4th Innovation Driven Water Sustainability Conference (IDWS) 2025 concluded on Wednesday in Jeddah, confirming its status as one of the world’s most influential platforms for shaping the future of water innovation, sustainability, and security. Gathering senior global policymakers and international industry leaders, this year’s edition has advanced critical dialogue on safeguarding the planet’s most vital resource, with Saudi Arabia at the forefront. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251216483490/en/ Investors, innovators, and global institutions gather in Saudi to outline how capital, collaboration, and governance can accelerate long term water sustainability (Photo: AETOSWire) Among the most consequential engagements were a series of meetings that brought together discussions powered by SWA, centred on shared challenges, knowledge exchange, and exploring opportunities within the global water ecosystem. Att
OAG Appoints ex-Skyscanner Executive Filip Filipov as New Chief Executive Officer16.12.2025 17:00:00 CET | Press Release
OAG announces today the appointment of Filip Filipov, ex-Skyscanner executive, as new Chief Executive Officer. Filip Filipov currently serves as the company’s Chief Operating Officer and takes over from Phil Callow who has chosen to step down having completed thirteen transformational years at the helm of OAG to pursue his many other interests. Since joining in 2024, Filipovhas played a leading role in the company’s ambitious next phase of growth and ongoing acceleration. He will now lead OAG into a new era defined by advanced data products and AI-driven intelligence. Before joining OAG, Filipov held senior roles in travel technology and big-data consulting, including on Skyscanner’s executive team. Filip Filipov said: “It’s a privilege to step into this role and lead a company with such a strong heritage and reputation. I’m excited for what’s ahead and committed to serving our customers with the reliability, service, and innovation they depend on.” Chairman of OAG, Gehan Talwatte, com
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
